JPRN-UMIN000032320尚未招募2 期
Examinations for immune-biological mechanism of anti-atherosclerotic effects of omega 3 lipid formula, Lotriga, focusing on commensal microbe and serum auto-antibodies. - Lotriga Residual Risk Reduction Trial LR3 Trial
Yokohama City University Graduate School of Medicine, Department of Medical Science and Cardio-Renal Medicine0 个研究点目标入组 36 人开始时间: 2018年4月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria are as follows: 1. Patients in whom Lotriga is contraindicated such as patients with a history of hypersensitivity to any ingredient of Lotriga or other omega-3 unsaturated fat, and patients who are bleeding with following conditions; hemophilia, capillary fragility disease, gastrointestinal ulcer, urinary tract bleeding, hemoptysis, vitreous hemorrhage, etc. 2. Patients with active infection or malignancies 3. Pregnant women, lactating women, and patients who wish to become pregnant 4. Patients who have not provided consent to participate in the study 5. Subjects with active inflammatory diseases or active malignant tumor. 6. Subjects who are already given other omega-3 unsaturated fat regimen. 7. Subjects who are already given other anti-hypertriglyceride medication such as fibrate derivatives, nicotinic acids derivatives. (Subjects who are already given statins are not excluded from participants.) 8. Subjects who are not in consent with research protocol. Furthermore, patients who meet the following criteria will be excluded: 1.Patients with symptomatic heart failure (NYHA class 2 or higher or EF < 40%) 2.Patients with possible type 1 diabetes mellitus 3.Patients who are scheduled to undergo coronary revascularization (Patients who underwent percutaneous transluminal coronary angioplasty including drug-eluting stent placement may be enrolled.) 4.Patients with serious liver or renal disorder 5.Patients who are determined to be not suitable by the investigator for reasons other than the above.
研究者
相似试验
尚未招募
3 期
Study of immunity to flu vaccine.CTRI/2021/11/037859Christian Medical College Vellore
招募中
不适用
Analysis of the immunological conditions in the intestinal mucosa of inflammatory bowel diseaseJPRN-UMIN000039795Internal Medicine (gastroenterlogy) Tokai University School of Medicine100
已完成
Unknown
Investigation of cell mediated immune response induced by varicella vaccinePrevention of herpes zosterJPRN-jRCT1080223477The Research Foundation for Microbial Diseases of Osaka University80
已完成
不适用
In vitro characterization of the immune response of recovered COVID-19 patients and healthy controls to SARS-CoV-2.CoronaCOVID-19SARS-CoV-210047438NL-OMON50131ISA Pharmaceuticals B.V.14
已完成
不适用
The role of innate immunity in the pathogenesis of acute respiratory syncytial virus lower respiratory tract infection: Repeated measurements of nasopharyngeal type 1 interferon levels in RSV infectionsInnate immune responseViral respiratory tract infection10024970NL-OMON35329RSV Research Group van het Wilhelmina Kinderziekenhuis Utrecht, UMCU, onder leiding van Prof. dr. J.L.L. Kimpen, promotor400